Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (126)

Date

2021 (19)
2020 (55)
2019 (6)
2018 (34)
2017 (12)

Results for "[search-keyword]"

Search

Sponsor content

126 result(s) found, displaying 111 to 120

OILATUM Medicated Mineral Oil BP 75mg/g Bar Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANADOL Elixir with Promethazine Bottle Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
FONGITAR SCALP CLEANSER application bottle Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
DUOFORTE PLANTAR WART TREATMENT cream tube Cancelled under s30(1)(c) of the Act

18 January 2018

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANADOL CLEAR 500 mg tablet - effervescent bulk Cancelled under s30(1)(c)

18 May 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANAFEN IBUPROFEN 200 mg tablet - film coated blister pack Cancelled under s30(1)(c)

18 May 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANADOL COLOURFREE LIQUID PARACETAMOL 24 mg/mL oral suspension bottle Cancelled under s30(1)(c)

18 May 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANAFEN IBUPROFEN 200 mg tablet - film coated blister dispensing pack Cancelled under s30(1)(c)

18 May 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANADOL ORIGINAL DROPS paracetamol 100mg/mL oral liquid bottle Cancelled under s30(1)(c)

18 May 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANAFEN IB TABLETS Ibuprofen 200mg tablet film-coated oral blister pack Cancelled under s30(1)(c)

18 May 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Current page 12
Page 13
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.